Market Cap (In JPY)
18.82 Billion
Revenue (In JPY)
190.13 Million
Net Income (In JPY)
-846.53 Million
Avg. Volume
1.93 Million
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 201.0-1160.0
- PE
- -21.12
- EPS
- -25.71
- Beta Value
- 1.117
- ISIN
- JP3423530009
- CUSIP
- -
- CIK
- -
- Shares
- 34666244.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Setsuko Hashimoto Ph.D.
- Employee Count
- -
- Website
- https://www.cellseed.com
- Ipo Date
- 2010-03-16
- Details
- CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis. The company also offers UpCell, a temperature-responsive cell cultureware for cell-sheet engineering; RepCell, a temperature-responsive cell cutureware for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides peripheral equipment, including ThermoPlate III, a heating element made by a transparent glass plate; and cellZscope, an automated cell monitoring system, as well as contract development and manufacturing services. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
More Stocks
-
ANG
-
SOUB
-
6614
-
CPMDCannaPharmaRX, Inc.
CPMD
-
CRFTFBC Craft Supply Co. Ltd.
CRFTF
-
GOODLUCKGoodluck India Limited
GOODLUCK
-
DTM
-
4240